Lp(a): When to Measure it and What to Do About it

Collaborative CME and Research Network

M. O'Donoghue

Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

Role of Coronary Calcification and Risk Stratification

The Texas Heart Institute

E. Hernandez

Recent Cholesterol Guidelines and Integration into Clinical Practice

Vasculearn Network

J. Plutzky, L. Braun, J. Ross

ACC 2022: Triple Therapy - When to Use and How Long

ACC 2022 Conference Coverage

D. Kumbhani

Do Triglycerides Cause Heart Disease?

National Lipid Association

I. Goldberg

Management of AF patients with ACS

Lankenau

P. Kowey, D. Ice

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

AHA 2022 Conference Coverage

N. Marston

Hypertension 2025: New Guidelines and Resistant Hypertension

University of Louisville

K. Ferdinand

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

Coronary Calcium Testing: Principles and Clinical Application

Right Care Initiative

A. Taylor

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

Evaluate the Horrible Cholesterol Lp(a): Prevalence, Impact and Nove…

Scripps Health

N. Lepor

Chest Pain in Emergency Department Settings

University Hospitals

G. Rao, R. Hughes

Time to Retire Aspirin?

Top Ten Topics in Clinical Cardiology 2021

R. Mehran

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

TCT 2024 Insights: Antiplatelet Therapy and All-Cause Mortality Afte…

TCT 2024 Insights

M. Zimarino

Heart Failure Case Presentations

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

B. Greenberg, G. Fonarow, N. Wettersten, M. Rosa Costanzo